Authors
Loading...
Review examines small molecules targeting splicing factors to address aberrant splicing in cancers, implying potential therapeutic benefits.
Yuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: